Dilbert, Roche, Lilly Grapple with Social Media

Tauzin on Roche/Genentech Leaving PhRMA: They Feel They Are Different

Making Sense of Pharma’s Recent M&A Spike

Notes from ISPE 2007: Facilities of the Year and Grace Under Pressure At Genentech

Boehringer-Ingelheim, Roche Drug Recalls Point to Manufacturing Problems; B-I Recall Reflects “Original” Marketing Tactic

Blogging from BIO 5 - Biotech’s Human Rights Responsibility